ArticleScientific reports2026
Effects of Lacticaseibacillus rhamnosus L156.4 and Lactococcus lactis NCDO 2118 strains on reducing alcohol intake and preference in an animal model of high alcohol consumption and preference.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Alcohol use disorder (AUD) involves a progressive series of neuroadaptations influenced by interactions along the gut-brain axis. Disruption of the intestinal barrier enables bacterial-derived metabolites and inflammatory mediators to translocate into the systemic circulation, amplifying neuroimmune activation within mesocorticolimbic reward circuits. Probiotic strains have emerged as promising adjuvant therapies for AUD due to their ability to regulate the gut microbiota and thereby influence neurotransmission. In this study, we investigated the potential of a probiotic blend containing the strains Lacticaseibacillus rhamnosus L156.4 and Lactococcus lactis NCDO 2118 to reduce alcohol intake and preference behaviors in a free-access drinking paradigm (H₂O vs. 10% v/v ethanol). The blend significantly decreased ethanol intake and preference and was accompanied by striatum upregulation of genes related to dopaminergic inhibitory control and downregulation of inflammation-related genes. Serum biochemical parameters remained unchanged and comparable between vehicle- and probiotic-treated groups, supporting the safety of the intervention. Additionally, we observed improved tissue integrity and structural restoration in both the colon and liver. Behavioral assessments using the open field test and marble-burying tests revealed reduced anxiety- and compulsive-like behaviors in the treated groups. These results suggest that this probiotic blend modulates distinct pathways, thereby attenuating alcohol`s rewarding effects and associated compulsive behaviors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.